Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

June 13 - 15, 2016
Parc 55 Hotel,
San Francisco, CA

PERFECT THE BIOCHEMISTRY BEHIND ADC SYNTHESIS, VACCINE AND NANOPARTICLE CONJUGATION

Thank you to everyone for attending this year's event

Where the drug discovery community gathers to

Develop Platforms to Support Novel Linkers and Payloads
  • Explore how the new class of DNA-alkylating agents are designed and synthesized
  • Mitigate toxicity risks and ensure proper potency with the latest data from Genentech and Immunogen
Take Your Products from Discovery to Commercialization
  • Combat analytical and characterization challenges with new data from MedImmune
  • Learn how Pfizer evaluates molecular complexity and critical quality attributes
  • Assess late stage commercial readiness with experts from Celgene, Medimmune, and Pfizer
Share Breakthroughs and Advances in Bioconjugation
  • Hear the latest data on bispecific, nano-particle, and vaccine conjugation
  • Eliminate heterogeneity and increase the therapeutic window with new data from GSK and Pfizer

The Leading Bioconjugates Meeting

100+
Attendees
20+
New Data sessions
10+
Hours of Dedicated Networking

2016 Sponsors and Exhibitors

Luncheon Presentation Sponsor